Sasol approved for secondary listing on A2X Markets


The listing provides shareholders with a variety of trading venue options, says Sasol CFO Paul Victor.

Sasol has been approved for a secondary listing on A2X Markets with effect from 3 February. It will retain its listings on the Johannesburg Stock Exchange and New York Stock Exchange

About listing, Sasol CFO Paul Victor said: 

“Sasol’s decision to list on A2X is part of the company’s commitment to continually find ways to increase value for shareholders as well as provide them with a variety of trading venue options.” 

According to a statement released by A2X, the listing will bring the number of securities available for trade on A2X to 34 with a combined market capitalisation of over R2 trillion. 

In welcoming Sasol to the platform A2X CEO Kevin Brady said that, as a global player with local roots and a pioneer in innovation for over six decades, “this is a great endorsement for the merits of a secondary listing”. 

He added that Sasol investors will benefit from “not only the direct saving of lower transaction fees on A2X but also the indirect savings that accrue as result of narrower and increased liquidity”. 

Related articles

CFO Jan Hofmeyr shares his blueprint for technological transformation

Passionate about the opportunity technology can bring, 2023 Finance & Technology Award winner Jan Hofmeyr has been breaking the CFO mould at OUTsurance by driving the transformation of its finance department so it remains relevant in an increasingly digital future. He reveals how this change has affected the entire business.

CFO Raisibe Morathi explores the nexus of connectivity

CFO Raisibe Morathi, CFO of the Year 2023 and winner of the Strategy Execution Award as well as the High-Performance Team Award, reveals how she balances technology and people to foster the ultimate digital, financial and cultural inclusion, as Vodacom Group transforms to become part of the digital revolution.

Bringing Joy to Discovery Health Medical Scheme as CFO

Discovery Health Medical Scheme CFO Joy Malete says that her rapid career progression has been the result of “divine orchestration”. Just 34, her success is rooted in curiosity, talent, and a true passion for what she does.